XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative-effect adjustment from adoption of ASU 2020-06
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative-effect adjustment from adoption of ASU 2020-06
Accumulated Other Comprehensive Loss/Income
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment from adoption of ASU 2020-06
Restricted Stock Units
Restricted Stock Units
Common Stock
Restricted Stock Units
Additional Paid-in Capital
Beginning balance (in shares) at Jan. 31, 2021     278,363                
Beginning balance at Jan. 31, 2021 $ 750,006   $ 28 $ 2,307,580   $ 7,410 $ (1,565,012)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon exercise of stock options (in shares)     1,331                
Issuance of common stock upon exercise of stock options 7,895     7,895              
Stock-based compensation expense 61,764     61,764              
Vesting of restricted stock units (in shares)                   3,082  
Vesting of restricted stock units                 $ 0   $ 0
Tax withholding on vesting of equity awards (in shares)     (226)                
Tax withholding on vesting of equity awards (5,050)     (5,050)              
Common stock issued under employee stock purchase plan (in shares)     2,185                
Common stock issued under employee stock purchase plan 17,726     17,726              
Repurchases of common stock (in shares)     (1,383)                
Repurchases of common stock (30,020)     (30,020)              
Other comprehensive loss (2,642)         (2,642)          
Net loss (84,206)           (84,206)        
Ending balance (in shares) at May. 02, 2021     283,352                
Ending balance at May. 02, 2021 715,473   $ 28 2,359,895   4,768 (1,649,218)        
Beginning balance (in shares) at Jan. 31, 2021     278,363                
Beginning balance at Jan. 31, 2021 750,006   $ 28 2,307,580   7,410 (1,565,012)        
Ending balance (in shares) at Feb. 06, 2022     292,633                
Ending balance at Feb. 06, 2022 $ 754,336 $ (35,127) $ 29 2,470,943 $ (133,265) (8,365) (1,708,271) $ 98,138      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                    
Issuance of common stock upon exercise of stock options (in shares)     1,233                
Issuance of common stock upon exercise of stock options $ 11,433     11,433              
Stock-based compensation expense 75,685     75,685              
Vesting of restricted stock units (in shares)                   3,608  
Vesting of restricted stock units                 $ 0 $ 1 $ (1)
Tax withholding on vesting of equity awards (in shares)     (295)                
Tax withholding on vesting of equity awards (10,194)     (10,194)              
Common stock issued under employee stock purchase plan (in shares)     2,087                
Common stock issued under employee stock purchase plan 19,396     19,396              
Repurchases of common stock (in shares)     (2,134)                
Repurchases of common stock (66,420)     (66,420)              
Other comprehensive loss (10,480)         (10,480)          
Net loss (11,535)           (11,535)        
Ending balance (in shares) at May. 08, 2022     297,132                
Ending balance at May. 08, 2022 $ 727,094   $ 30 $ 2,367,577   $ (18,845) $ (1,621,668)